These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36613659)

  • 1. A Meta-Analysis Study of SOD1-Mutant Mouse Models of ALS to Analyse the Determinants of Disease Onset and Progression.
    Ciuro M; Sangiorgio M; Leanza G; Gulino R
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
    Shibata N
    Neuropathology; 2001 Mar; 21(1):82-92. PubMed ID: 11304046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
    Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
    Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex.
    Zhang F; Ström AL; Fukada K; Lee S; Hayward LJ; Zhu H
    J Biol Chem; 2007 Jun; 282(22):16691-9. PubMed ID: 17403682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT1 overexpression ameliorates a mouse model of SOD1-linked amyotrophic lateral sclerosis via HSF1/HSP70i chaperone system.
    Watanabe S; Ageta-Ishihara N; Nagatsu S; Takao K; Komine O; Endo F; Miyakawa T; Misawa H; Takahashi R; Kinoshita M; Yamanaka K
    Mol Brain; 2014 Aug; 7():62. PubMed ID: 25167838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenretinide Beneficial Effects on Amyotrophic Lateral Sclerosis-associated SOD1
    Orienti I; Armida M; Dobrowolny G; Pepponi R; Sollazzini G; Pezzola A; Casola I; Musarò A; Popoli P; Potenza RL
    Neuroscience; 2021 Oct; 473():1-12. PubMed ID: 34363869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublethal enteroviral infection exacerbates disease progression in an ALS mouse model.
    Xue YC; Liu H; Mohamud Y; Bahreyni A; Zhang J; Cashman NR; Luo H
    J Neuroinflammation; 2022 Jan; 19(1):16. PubMed ID: 35022041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
    Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
    Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive Degeneration and Inhibition of Peripheral Nerve Regeneration in the SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis.
    Deng B; Lv W; Duan W; Liu Y; Li Z; Ma Y; Zhang G; Song X; Cui C; Qi X; Li Y; Li C
    Cell Physiol Biochem; 2018; 46(6):2358-2372. PubMed ID: 29742495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
    Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
    J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALS pathogenesis: recent insights from genetics and mouse models.
    Swarup V; Julien JP
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):363-9. PubMed ID: 20728492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.
    Turner BJ; Ackerley S; Davies KE; Talbot K
    Hum Mol Genet; 2010 Mar; 19(5):815-24. PubMed ID: 20008901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.
    Turner BJ; Parkinson NJ; Davies KE; Talbot K
    Neurobiol Dis; 2009 Jun; 34(3):511-7. PubMed ID: 19332122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice.
    Pan L; Yoshii Y; Otomo A; Ogawa H; Iwasaki Y; Shang HF; Hadano S
    PLoS One; 2012; 7(3):e33409. PubMed ID: 22438926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
    Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
    Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Implications of successful immunotherapy in ALS model mice].
    Urushitani M
    Brain Nerve; 2008 Jun; 60(6):643-51. PubMed ID: 18567360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
    Han Y; Ripley B; Serada S; Naka T; Fujimoto M
    PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
    Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
    Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.